Cargando…
Antitumor effects of Dasatinib on laryngeal squamous cell carcinoma in vivo and in vitro
A novel drug named Dasatinib is a highly potent ATP-competitive orally active dual Src/Abl kinase inhibitor with anti-proliferative activity against solid tumors and CML (chronic myeloid leukaemia) cell lines. Dasatinib has been shown to have preclinical activity against human prostate, breast, panc...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer-Verlag
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608870/ https://www.ncbi.nlm.nih.gov/pubmed/23404469 http://dx.doi.org/10.1007/s00405-013-2394-3 |